Gocovri (Amantadine Extended Release Capsules, for Oral Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 8, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Gocovri (amantadine) for the Treatment of Dyskinesia in Parkinson's Disease Patients
EMERYVILLE, Calif., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (FDA) has approved Gocovri (amantadine) extended release capsules (previously ADS-5102) for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 24, 2017 Category: Drugs & Pharmacology Source Type: news

Apace Packaging LLC Issues Voluntary Nationwide Recall of Cyclobenzaprine HCL and Amantadine HCL (Lot 16710) Due to Potential Mislabeling
Apace Packaging LLC is voluntarily recalling one lot of Cyclobenzaprine HCl Tablet, USP 5 mg 50ct Unit Dose, NDC# 50268-190-15, Lot Number 16710 and one lot of Amantadine HCl Capsule, USP 100 mg 50ct Unit Dose NDC# 50268-069-15, Lot Number 16710 to the Retail level. These products have been recalled due to a potential mislabeling. A small number of cartons containing Cyclobenzaprine HCl Tablets 5 mg UD Blister Cards may potentially be mislabeled as Amantadine HCl Capsules, USP 100 mg. The unit dose blisters inside the carton are correctly labeled as Cyclobenzaprine HCl Tablet, USP 5 mg. (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 27, 2017 Category: Food Science Source Type: news

Stroke patient speaks due to Parkinson's disease drug
An unnamed patient, 36, believed to be from Berlin, who was only being kept alive by medical intervention, was able to speak in short sentences after being given the drug amantadine. (Source: the Mail online | Health)
Source: the Mail online | Health - July 26, 2017 Category: Consumer Health News Source Type: news

Corneal Edema: Is Your Patient Receiving Amantadine? Corneal Edema: Is Your Patient Receiving Amantadine?
Amantadine-induced corneal edema, which can mimic a number of other ocular conditions, is best treated simply by discontinuation of the drug.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Extended-Release Amantadine Effective for Dyskinesia in PD Extended-Release Amantadine Effective for Dyskinesia in PD
A phase 3 study shows a once-daily formulation of amantadine is superior to placebo in reducing severity and duration of levodopa-induced dyskinesia in patients with Parkinson ' s.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 21, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg
PHILADELPHIA, June 16, 2017 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Amanta... Biopharmaceuticals, Generics, FDA Lannett, Amantadine, Symmetrel, influenza (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2017 Category: Pharmaceuticals Source Type: news

New Amantadine Pill Cuts Dyskinesia in Parkinson's (CME/CE)
(MedPage Today) -- But questions about cost-effectiveness remain (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - June 12, 2017 Category: Consumer Health News Source Type: news

Drug reduces dyskinesia, 'off' times in Parkinson's patients
(Reuters Health) - An experimental extended-release version of the drug amantadine can reduce the duration of the involuntary dancing-like movements seen in people whose long-term use of levodopa has kept their Parkinson ’s disease under control. (Source: Reuters: Health)
Source: Reuters: Health - June 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

New NIST data to aid production and storage of 'fascinating' medication
(National Institute of Standards and Technology (NIST)) Amantadine hydrochloride may be the most common medication you've never heard of. Now, chemists at the National Institute of Standards and Technology (NIST) and collaborators have published the very first data on this important chemical's thermodynamic properties, including data on how it responds to heat and changes from a solid into a gas. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 2, 2017 Category: Global & Universal Source Type: news

New Amantadine Formulation May Improve Walking in MS New Amantadine Formulation May Improve Walking in MS
Phase 2 results show significant walking speed improvement in patients with MS who received an investigational formulation of amantadine hydrochloride ER and ' warrant further development, ' say investigators.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 1, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Symmetrel (Amantadine Hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2017 Category: Drugs & Pharmacology Source Type: news

Adamas Announces U.S. FDA Acceptance of ADS-5102 New Drug Application for the Treatment of Levodopa-induced Dyskinesia in Patients with Parkinson's Disease
EMERYVILLE, Calif., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ADS-5102 (amantadine... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - January 6, 2017 Category: Drugs & Pharmacology Source Type: news

Acute hallucinosis related to amantadine use in the setting of traumatic brain injury: a case report - Schoen B, Eickmeyer S.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - October 1, 2016 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Adjunctive amantadine treatment for aggressive behavior in children: a series of eight cases - McGrane IR, Loveland JG, Zaluski HJ.
We describe our experience with adjunctive amantadine treatment for... (Source: SafetyLit)
Source: SafetyLit - August 4, 2016 Category: Global & Universal Tags: Age: Infants and Children Source Type: news